Pancreatic ductal adenocarcinoma is a highly metastatic disease associated to KRAS Proto-Oncogene, GTPase (KRAS) gene mutations, occurring to > 90% of the patients [259]. The gene discussed is KRAS; the disease is metastatic neoplasm.